Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPA-MEST: Surgery vs Eplerenone in Unilateral Primary Aldosteronism
NCT05797558Recruiting
- Sponsor
- University of Gothenburg
- Start
- Apr 2023
- Primary completion
- May 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of eplerenone in primary aldosteronism (PA) (2 arms), sponsored by University of Gothenburg. Primary endpoint: Quality of Life evaluated with EuroQol-5D at 12 months. Started Apr 2023; status: recruiting.
02
Drugs
eplerenone
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NCT05797558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05797558.